More about

Ocular Hypertension

News
December 15, 2022
1 min read
Save

Iyuzeh approved for IOP reduction in open-angle glaucoma, ocular hypertension

Iyuzeh approved for IOP reduction in open-angle glaucoma, ocular hypertension

The FDA approved Iyuzeh for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, according to a press release from Thea Pharma.

News
September 30, 2022
2 min watch
Save

VIDEO: SpyGlass CEO gives update on IOP-lowering drug delivery platform

VIDEO: SpyGlass CEO gives update on IOP-lowering drug delivery platform

CHICAGO — In this video from Eyecelerator@AAO, SpyGlass Pharma CEO Patrick Mooney discusses the company’s drug delivery platform, which lowered IOP in patients with open-angle glaucoma or ocular hypertension.

News
August 25, 2022
3 min read
Save

BLOG: Cataract diagnosis can be good news for patients with ocular hypertension

BLOG: Cataract diagnosis can be good news for patients with ocular hypertension

Ocular hypertension is a risk factor for glaucoma, but in the absence of any glaucomatous damage it does not necessitate medical intervention.

News
April 06, 2022
1 min read
Save

Deep learning algorithm shows accuracy in detecting glaucoma on fundus photographs

Automated deep learning analysis of fundus photographs showed high diagnostic accuracy in determining primary open-angle glaucoma, with increased ability to detect glaucoma earlier than human readers.

News
February 24, 2022
2 min read
Save

Age, gender, corneal thickness linked to elevated IOP in glaucoma, OHT

Age, gender and central corneal thickness were among factors associated with elevated IOP in patients with primary open-angle glaucoma and ocular hypertension, according to a study published in British Journal of Ophthalmology.

News
February 22, 2022
2 min read
Save

High 20-year incidence of primary open-angle glaucoma in OHT

The cumulative incidence of primary open-angle glaucoma after 20 years was almost 50% in patients with ocular hypertension, and the cumulative incidence of visual field loss was 25%, according to a study published in JAMA Ophthalmology.

News
December 16, 2021
1 min read
Save

First patient in China screened in phase 3 trial of NCX 470 for glaucoma

First patient in China screened in phase 3 trial of NCX 470 for glaucoma

The first patient in the Chinese portion of the Denali phase 3 clinical trial, investigating NCX 470 in patients with open-angle glaucoma or ocular hypertension, has been screened, according to a press release from Nicox.

News
November 02, 2021
2 min read
Save

Self-tonometry consistently measures diurnal IOP fluctuations

Self-tonometry consistently measures diurnal IOP fluctuations

Self-tonometry consistently evaluated diurnal IOP fluctuations in patients with ocular hypertension or open-angle glaucoma, according to a crossover clinical treatment trial in Optometry and Vision Science.

News
August 30, 2021
2 min read
Save

Netarsudil lowers IOP when added to other treatments

Netarsudil maintained IOP control and provided IOP-lowering efficacy when added to other treatments for patients with open-angle glaucoma or ocular hypertension, according to findings published in Current Medical Research and Opinion.

News
June 18, 2021
3 min read
Save

BLOG: Patient has anterior chamber pigment after LASIK

An interesting case was recently discussed among the optometrists and surgeons at Pacific Cataract and Laser Institute.

View more